Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells
about
bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNAThe v-myc oncogene.In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes.Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesisJAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1.Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells.Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line.bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.Restriction of neuroblastoma to the prostate gland in transgenic mice.Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl.Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures.The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.The 5' noncoding region of the human leukemia-associated oncogene BCR/ABL is a potent inhibitor of in vitro translation.Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemiasClonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative function.Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.Interactions of retroviral and cellular transforming genes with hematopoietic cells.A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production.Stably transmitted triple-promoter retroviral vectors and their use in transformation of primary mammalian cells.Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine.Negative autoregulation of c-myc transcription.Negative autoregulation of c-myc gene expression is inactivated in transformed cells.Independent and synergistic activity of rol A, B and C loci in stimulating abnormal growth in plants.Antigen presentation after macrophage lineage switch of CD5 pre-B cells.Several types of adherent cells elaborate a dialyzable lymphopoietic cofactor (Abelson Growth Promoter).Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts.
P2860
Q24647092-63F5959D-2FF0-431E-B10F-A9FEE3BCF23EQ33667333-D9FC3C9F-8998-4FA8-90CF-DB826484EC65Q34347155-A9F0276F-D96E-4C6D-BF94-8DE52831F47EQ34373203-BE9CA5BB-641B-4C3C-B55C-48B2E76B25C3Q34998323-D07C4A08-5502-4897-801C-51FFC76E9F3DQ35635353-D4BC1629-9B02-4063-ABC0-356E6E7DC37FQ36028499-CEB60E74-9C91-480A-ADE5-0412D08DA4DBQ36261980-DB85F06A-47F0-485C-BBF1-1C1053B6D473Q36361648-759067F9-0D6A-45F0-9226-56D0382E64D4Q36684210-FDD8F627-027E-4531-B618-30180D19920BQ36721559-7B132BD9-DBAB-4822-B951-AEC64F80825EQ36731640-95D612D2-459D-4474-996A-42CCFF296DFAQ36752903-6D5B2989-9209-4E21-8CD7-070E72608955Q36760642-D33851EA-0291-4805-AF3C-3B3B0B3EF6B4Q36768150-1B1156C4-50D3-4A27-BC51-B33CEF50B6D0Q36776463-4366A731-A1D1-47C9-AB27-96425B74FAF6Q36796574-05A88C2E-2E9D-4656-B1DE-6491D334A7A4Q36846338-08D78E8C-32E1-4F01-BF2D-62C3D9978190Q36874189-F17242FF-99B1-4CC9-8A5A-D4B602F3F72BQ36918561-D67C5B92-0C72-421E-B615-5EF7F4C62FD2Q37712608-479F1908-7F32-4335-BEBB-7FA23ED7FE78Q39610851-41B8A448-E558-4795-8A86-B70183E4E0EBQ39695020-2CC21BAA-E6C7-43EE-97D0-B1B9839F17B5Q40646616-998E0F30-B159-42A9-A23C-D86FC1B053ACQ40649557-CF7DB6CD-6617-47AB-8300-1A23430313C0Q40677768-F294C079-7144-4364-A9DC-F33DCB7874D0Q41206626-979BDA94-8DFA-4F54-92E0-D0A81E2569F9Q41233339-606EE7CC-B137-4255-B023-39BE37EE9032Q41358424-45129151-B8EB-4FD7-9019-642852850FC1Q41624892-335B1D99-7D43-4559-B54E-FEACC520B3DAQ41715468-2E9E2AA8-6F71-4BF9-A0B5-9465E4485EDEQ42817686-D6423D6C-48A5-47A2-9255-542FA6FE0B06
P2860
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Synergism of v-myc and v-Ha-ra ...... ssion of murine lymphoid cells
@en
type
label
Synergism of v-myc and v-Ha-ra ...... ssion of murine lymphoid cells
@en
prefLabel
Synergism of v-myc and v-Ha-ra ...... ssion of murine lymphoid cells
@en
P2093
P2860
P356
P1476
Synergism of v-myc and v-Ha-ra ...... ssion of murine lymphoid cells
@en
P2093
P2860
P304
P356
10.1128/MCB.6.9.3221
P407
P577
1986-09-01T00:00:00Z